In this podcast, Jennifer Sherwood, PhD, and Elise Lankiewicz, MPH, speak about the current state of transgender inclusion in national HIV strategic plans (NSPs) globally, the results from the recent...
In this interview, Jessica Rodrigues, MS, answers questions about barriers to the access of pre-exposure prophylaxis (PrEP), funding, stigma, and choices of PrEP. She also spoke about these topics during...
In this podcast, Davina Canagasabey, with PATH, speaks about delivering responsive, person-centered HIV and primary health care. She also spoke about this topic during her presentation at the International...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, speaks about ways communities can overcome barriers to the access of pre-exposure prophylaxis (PrEP), including ambitious...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, provides a description of a Dual Prevention Pill and why it can be used as a case study for future multipurpose...
In this podcast, Raphael Landovitz, MD, discusses the findings from his recent trial, HPTN 083, which indicates that long-acting cabotegravir injected once every 8 weeks is superior to daily oral TDF/FTC in...
